CS logo
small CS logo
ARTMEDI UPD s.r.o.

Hostivice, Czechia
Rheumatologist in Hostivice
Čsl. armády 18, 253 01 Hostivice

About ARTMEDI UPD s.r.o.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
3
Pfizer
3
AB Science
1
Total Rows: 3

Clinical Trials at ARTMEDI UPD s.r.o.


During the past decade, ARTMEDI UPD s.r.o. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
2007-11-01
2011-11-01
Completed
1,457
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
2010-10-01
2013-11-01
Completed
109
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-09-27
2017-01-25
Completed
488
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
2010-12-09
2012-09-10
Terminated
237
Masitinib in Refractory Active Rheumatoid Arthritis
2011-07-01
2015-10-01
Terminated
324
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
2012-05-02
2018-10-25
Completed
490

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 3Amgen: 3Pfizer: 3Pfizer: 3AB Science: 1AB Science: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at ARTMEDI UPD s.r.o.


According to Clinical.Site data, the most researched conditions in "ARTMEDI UPD s.r.o." are "Rheumatoid Arthritis" (2 trials), "Ankylosing Spondyloarthritis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Osteoarthritis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "ARTMEDI UPD s.r.o." in a lesser frequency.

Clinical Trials Intervention Types at ARTMEDI UPD s.r.o.


Most popular intervention types in "ARTMEDI UPD s.r.o." are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Apremilast 20 mg" (1 trials), "Apremilast 20mg" (1 trials), "Apremilast 30 mg" (1 trials) and "Apremilast 30mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ARTMEDI UPD s.r.o.


The vast majority of trials in "ARTMEDI UPD s.r.o." are 7 trials for "All" genders.

Clinical Trials Status at ARTMEDI UPD s.r.o.


Currently, there are NaN active trials in "ARTMEDI UPD s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ARTMEDI UPD s.r.o., undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in ARTMEDI UPD s.r.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 4Phase 2: 4Phase 3: 4Phase 3: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Terminated: 2Terminated: 2